Want more wrestling news, rumors, and results? Be sure to visit PWInsider.com and PWInsiderXtra.com.
The cannabis industry has been growing unprecedentedly over the last decade, creating numerous opportunities for investors. As the sector matures, companies within the cannabis ecosystem, including growers, processors, and retailers, are seeing increased investor interest. The year 2025 is expected to continue this trend, with cannabis stocks poised to deliver solid returns. In this article, we’ll explore the best-performing cannabis stocks for 2025, explore the factors driving their success, and examine how products like Delta 8 gummies contribute to the industry’s growth.
The global cannabis market has expanded significantly since the legalization of medical and recreational cannabis in several countries and states. In North America, the U.S. and Canada have led the way in terms of legalizing cannabis products. The European market is also catching up, with countries like Germany, Luxembourg, and Portugal making strides toward legal cannabis.
Analysts project that the global cannabis market could grow to $100 billion by 2030, making it an attractive sector for investors. This growth is fueled by shifting consumer perceptions, advances in cannabis-based medical treatments, and expanding product offerings that appeal to diverse audiences. Notably, products like Delta-8 gummies and other THC-based edibles are quickly gaining popularity, contributing to the demand for cannabis-derived goods.
Now, let’s dive into the top cannabis stocks to watch in 2025.
Curaleaf Holdings is one of the largest vertically integrated cannabis companies in the U.S. With operations in 23 states and a diverse product portfolio that includes flower, edibles, and concentrates, Curaleaf has established itself as a key player in the market. The company's strength lies in its vast retail network and extensive range of cannabis products.
Curaleaf’s strong presence in both the medical and recreational cannabis markets positions it well for 2025. The company is continually expanding its product lineup to cater to consumer trends, including the increasing demand for Delta-8 and Delta-9 THC products. Curaleaf’s focus on innovation, such as developing premium edibles like Delta-8 gummies, provides an additional revenue stream in a growing niche. Investors seeking exposure to a well-established cannabis player with consistent growth should keep an eye on Curaleaf.
Green Thumb Industries (GTI) has built a reputation as one of the most stable and profitable cannabis companies in the U.S. The company's growth strategy focuses on expanding its retail footprint and developing a diversified product line, including high-demand categories like gummies and other edibles. With over 80 retail locations across the U.S., GTI is well-positioned to capitalize on the expanding cannabis market.
The company’s focus on operational efficiency and profitability has been key to its success. GTI has consistently reported positive cash flow, which sets it apart from many competitors. One of the most interesting aspects of GTI’s product offerings is its growing line of edibles, including Delta-8 and Delta-9 THC gummies, which have seen increased consumer demand due to their less intense psychoactive effects compared to traditional THC products.
For 2025, GTI is expected to continue its growth trajectory, driven by increasing consumer demand for edibles and a growing retail presence.
Trulieve Cannabis is another major player in the U.S. cannabis market. Known for its focus on the medical cannabis space, Trulieve operates over 180 dispensaries, primarily in Florida, where it holds a dominant market share. The company has been steadily expanding its footprint into other states, including Massachusetts, Arizona, and Pennsylvania.
Trulieve’s competitive advantage lies in its robust cultivation and distribution infrastructure, which enables it to maintain high product quality and consistency. As consumer preferences evolve, Trulieve has adapted by offering a wide range of products, including Delta-8 THC gummies. Delta-8, a milder version of Delta-9 THC, has become a popular choice among consumers seeking a more subtle high, and Trulieve is well-positioned to benefit from this trend.
In 2025, Trulieve’s focus on medical cannabis, coupled with its growing product offerings in the recreational space, makes it a strong contender for investors seeking growth opportunities in the cannabis sector.
Tilray is one of the few cannabis companies with a significant presence in both the North American and European markets. Originally a Canadian cannabis producer, Tilray has since expanded into the U.S. through its merger with Aphria. The company’s diverse product portfolio includes medical cannabis, recreational cannabis, hemp, and CBD products.
Tilray’s focus on expanding its presence in international markets, particularly in Europe, positions it well for long-term growth. The company has also entered the cannabis edibles space, including Delta-8 gummies, to cater to the rising demand for alternative consumption methods.
For 2025, Tilray’s ability to leverage its global presence and diversify its product offerings will be key to its success. Investors interested in a cannabis stock with international exposure should consider Tilray.
Canopy Growth Corporation has long been one of the most recognized names in the cannabis industry. Based in Canada, Canopy Growth has expanded into the U.S. through strategic partnerships and acquisitions. The company’s diverse product portfolio includes flower, oils, beverages, and edibles, making it one of the most versatile cannabis companies in the market.
One of Canopy Growth’s key growth areas is the edibles segment, where it has introduced Delta-8 gummies to its product lineup. These gummies have gained popularity due to their milder psychoactive effects, making them appealing to both new and experienced cannabis users. Canopy’s focus on product innovation and expanding into new markets will likely drive growth in 2025.
Although Canopy Growth has faced some challenges in recent years, its strategic moves to enter the U.S. market and expand its product offerings make it a stock to watch in 2025.
Delta-8 THC, a cannabinoid found in smaller amounts in cannabis plants, has become increasingly popular in recent years due to its less potent psychoactive effects compared to Delta-9 THC. Consumers looking for a milder high have turned to Delta-8 products, particularly gummies, as an alternative to traditional cannabis products.
Delta-8 gummies have grown in popularity for several reasons:
Milder Effects: Delta-8 THC offers a more subtle high compared to Delta-9 THC, making it appealing to new users or those who prefer a less intense experience.
Legality: In some regions, Delta-8 THC occupies a legal gray area, making it more accessible in markets where Delta-9 THC remains restricted.
Versatile Use: Gummies are an easy-to-consume, discreet option for those who don’t want to smoke or vape cannabis. The edible market, especially gummies, is experiencing substantial growth, with Delta-8 products playing a key role.
As consumer interest in alternative cannabis products like Delta-8 gummies continues to rise, cannabis companies that offer a wide range of edibles are positioned to capture a larger share of the market.
As the cannabis industry matures and new product trends emerge, cannabis stocks offer investors a unique opportunity for growth. Companies like Curaleaf, Green Thumb Industries, Trulieve, Tilray, and Canopy Growth are well-positioned to perform strongly in 2025 due to their diverse product offerings and expanding retail footprints.
Delta-8 gummies and other edibles are becoming a key part of the cannabis ecosystem, appealing to a broader audience of consumers. As these products gain popularity, they will likely continue to drive growth in the sector, making the cannabis market an exciting space for investors looking ahead to 2025.
If you enjoy PWInsider.com you can check out the AD-FREE PWInsider Elite section, which features exclusive audio updates, news, our critically acclaimed podcasts, interviews and more by clicking here!
Bang On Casino
